Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721393 · ClinicalTrials.gov registry record
Data Collection - Of Syncope Tilt Table Testing Study
A clinical trial of Orthostatic Hypotension and Reflex Syncope, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03721393: Completed study of Orthostatic Hypotension and Reflex Syncope, sponsored by Boston Scientific Corporation.
NCT03721393 is a study of Orthostatic Hypotension and Reflex Syncope that has completed, run by Boston Scientific Corporation. The registered enrollment target is 50 participants, roughly in line with the 49-participant average among 16 other Orthostatic Hypotension trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721393, a study of Orthostatic Hypotension and Reflex Syncope, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.
Primary Outcome
Characterize the impact of orthostatic hypotension (OH) and reflex syncope on physiologic signals measured using a wearable cardiac monitor prototype device.
Conditions Studied
Interventions
- DEVICE Wearable heart monitor
Study Locations (1)
Minnesota
- Mayo Clinic Foundation - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-10-04 |
| Est. Completion | 2023-05-08 |
What the finished NCT03721393 record still lists
NCT03721393 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, roughly in line with the 49-participant average among 16 other Orthostatic Hypotension trials with a reported enrollment target.
The record links to 2 conditions, with Orthostatic Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Wearable heart monitor is the first listed.
NCT03721393 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03721393 about?
NCT03721393 is a clinical study titled "Data Collection - Of Syncope Tilt Table Testing Study". To characterize the impact of orthostatic hypotension (OH) and reflex syncope on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of signals measured from the wearable cardiac monitor prototype device with reported symptom severity of orthostatic into...
What is the current status of trial NCT03721393?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-10-04. Estimated completion is 2023-05-08.
What conditions does trial NCT03721393 study?
This clinical trial studies the following conditions: Orthostatic Hypotension, Reflex Syncope.
What interventions are being tested in trial NCT03721393?
The interventions under investigation include: Wearable heart monitor (DEVICE).
Who is sponsoring clinical trial NCT03721393?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03721393 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orthostatic Hypotension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03721393's enrollment target sits among peer trials
50 4th of 16 higher than 13 of 16 other Orthostatic Hypotension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Orthostatic Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
Deciphering Preserved Autonomic Function After Spinal Cord Injury
RECRUITING · NA
-
Autonomic Effects of Spinal Cord Stimulation in Spinal Cord Injury
RECRUITING · NA
-
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
RECRUITING · Phase 1
-
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI